You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Health Research Articles
Popular Health Research Articles
Highly Recommended Health Research Articles
Send a link to this page to your friends and colleagues.
A study in the September issue of Obesity Research suggests that the anti-depressant drug bupropion (Wellbutrin) is effective at producing weight loss.
According to Reuters Health, the study is the first randomized, placebo-controlled trial to show that the drug may be effective in non-depressed, obese subjects.
Researchers from Duke University Medical Center in Durham, North Carolina, randomized 50 non-depressed overweight and obese women in an eight-week trial. Subjects began with once-daily, 100-mg doses of Wellbutrin or placebo. Dosages were gradually increased to 200 mg twice daily. Patients who responded to therapy continued treatment for an additional 16 weeks.
The patients were also prescribed a 1,600-calorie-per-day diet and were given food diaries to help ensure compliance.
Reuters reports that over the first eight weeks, Wellbutrin-treated subjects achieved a mean weight loss of 4.9 percent, compared to 1.3 percent by placebo-treated subjects. The average weight loss among the 14 Wellbutrin patients who completed 24 weeks of therapy was 12.9 percent with fat accounting for most of the loss.
0 comments - Dec 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.